Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Outcomes of patients with esophageal cancer staged with [¹8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

Outcomes of patients with esophageal cancer staged with [¹8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol. 2010 Nov 01; 28(31):4714-21.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.